Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

This study has been completed.
Sponsor:
Collaborators:
Cellvizio Inc.
Emissary International LLC
Information provided by:
Mauna Kea Technologies
ClinicalTrials.gov Identifier:
NCT00779688
First received: October 22, 2008
Last updated: February 9, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)